Behavioral
APS
APS is a behavioral intervention with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_1
1
20%
Ph not_applicable
3
60%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(4)
Detailed Status
Completed4
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (25.0%)
N/A3 (75.0%)
Trials by Status
completed480%
not_yet_recruiting120%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable
Replication and Evaluation of the RISE-APS Model In New Contexts
NCT07368257
completednot_applicable
APSS-33-00: A Multicenter, Pilot Study of Autologous Protein Solution (APS) in Knee Osteoarthritis (OA)
NCT02138890
completed
Prospective Post-Market Data Collection on Patients With Knee OA and Treated With nSTRIDE APS
NCT02580643
completedphase_1
Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)
NCT02262364
completednot_applicable
The Utility of Pretracheal Stethoscope in Detecting Respiratory Abnormalities in Sedated Children
NCT01957566
Clinical Trials (5)
Showing 5 of 5 trials
NCT07368257Not Applicable
Replication and Evaluation of the RISE-APS Model In New Contexts
NCT02138890Not Applicable
APSS-33-00: A Multicenter, Pilot Study of Autologous Protein Solution (APS) in Knee Osteoarthritis (OA)
NCT02580643
Prospective Post-Market Data Collection on Patients With Knee OA and Treated With nSTRIDE APS
NCT02262364Phase 1
Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)
NCT01957566Not Applicable
The Utility of Pretracheal Stethoscope in Detecting Respiratory Abnormalities in Sedated Children
All 5 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 5